- Lexaria is ahead of the game in the expected second flow of investment capital in “plant-to-bloodstream” companies
- Company’s DehydraTECH™ technology has the potential to revolutionize nicotine use, eliminating the major cause of related deaths by shifting demand away from smoking cigarettes
- DehydraTECH™ makes it possible to experience most of the positives associated with inhalation while eliminating the negatives, helping to make lighting up a thing of the past
Within the cannabis industry, the initial flow of investment capital has been toward ‘seed-to-plant’ companies. As the next stage of investment is expected to be ‘plant-to-bloodstream’, companies such as Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) are positioned ahead of the game. LXRP’s revolutionary DehydraTECH™ technology disrupts the traditional ways that cannabinoids enter the bloodstream, including through inhalation, under the tongue and through edibles. Each of these three historic methods have their own challenges.
First, inhalation is unhealthy, allowing toxins from the combustion process to enter the bloodstream. People die every day from smoking cigarettes, and no rational person can argue in favor of smoking. Second, edible producers often mask the bitter taste of hemp oils and cannabis oils through the use of excessive sugar or unwanted artificial sweeteners. Additionally, the active ingredients are broken down by the…
More from NetworkNewsWire
NetworkNewsWire (NNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) NetworkNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, NNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. NNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, NNW brings its clients unparalleled visibility, recognition and brand awareness. NNW is where news, content and information converge.
For more information please visit https://www.NetworkNewsWire.